# US 2016/0251340 A1 · Hydantoin derivatives useful as kv3 inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251340 A1
- Document ID: US20160251340A1
- Status: Published application
- Kind: A1
- Application number: 15/093,004
- Filed: 2016-04-07
- Published: 2016-09-01
- Earliest claimed: 2010-12-06
- Assignees: Autifony Therapeutics Limited
- Applicants: Autifony Therapeutics Limited
- Inventors: Giuseppe ALVARO; Paolo DAMBRUOSO; Simona TOMMASI; Anne DECOR; Charles LARGE; Agostino MARASCO
- Web page: https://patentgrep.com/patent/US20160251340A1

## CPC

- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/20: Hypnotics; Sedatives
- A61P 25/24: Antidepressants
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 27/16: Otologicals
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 307/79: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D 307/94: spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
- C07D 317/46: condensed with one six-membered ring
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

## Claims

### Claim 1

A compound selected from:
spiro[1-benzofuran-3,1′-cyclopropan]-4-ol
7-methylspiro[2H-benzofuran-3,1′-cyclopropane]-4-ol
and
3,3,7-trimethyl-2,3-dihydro-1-benzofuran-4-ol
or a salt thereof; or
a compound selected from:
wherein:
X is C or N;
Y is C or N; and
the group W is selected from:
or a salt thereof.
